Orphan Medical Xyrem Central Pharmacy Will List Prescribers Under DEA Rule
This article was originally published in The Pink Sheet Daily
Executive Summary
A Drug Enforcement Administration rule will require pharmacies dispensing products containing gamma hydroxybutyrate such as Xyrem to compile the names of the prescribing practicioner. Xyrem is distributed through a single pharmacy.
You may also be interested in...
Orphan Medical Xyrem Planned sNDA Will Aim For First-Line Narcolepsy Claim
Phase IIIb trial in excessive daytime sleepiness supports expanding label to include all of narcolepsy, firm says. EXCEEDS data suggest optimal outcomes for Xyrem and Cephalon’s Provigil used together; sNDA planned by year-end.
NME Slowdown Shows Market Pressure On Me-Toos, Not FDA Caution – Lutter
DURHAM, N.C. - The decline in FDA's tally of new molecular entity approvals stems from fewer approvals of non-innovative products in recent years, while approvals of truly innovative products has largely held steady, according to FDA Deputy Commissioner for Policy, Planning and Preparedness Randall Lutter
Amgen Aranesp, Vectibix Setbacks Illustrate Risks Of Real World Trials
Amgen's failed Anemia of Cancer trial of Aranesp and Panitumumab Advanced Colorectal Cancer Evaluation (PACCE) trial of Vectibix may illustrate the potential pitfalls facing sponsors that conduct "real world" trials of their products